Uses of celastrol in preventing and/or treating cholestatic liver disease and liver fibrosis
US11607417B2 · kind B2 · utility
0Cited by
0References
4Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Mar 9, 2018 |
| Grant date | Mar 21, 2023 |
| Priority date | — |
| Expiry date | Jul 30, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/56
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to a celastrol or a pharmaceutically acceptable salt thereof, and a use thereof in the manufacture of a medicament for preventing and/or treating a cholestatic liver disease or a liver fibrosis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.